Security key
09074H203
BIOTRICITY INC. - Common Stock, par value $0.001 per share (BTCY)
CUSIP: 09074H203
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 481,039
- Total 13F value
- $431,539
- Share change
- +134,278
- SEC-reported price per share
- $0.90
- Number of holders
- 19
- Value change
- +$120,741
- Number of buys
- 9
- Number of sells
- 3
- Shares outstanding
- 32,745,152
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
19
Top holders
10
BTCY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
BIOTRICITY INC. SEC filings
BIOTRICITY INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09074H203
Recent filing periods:
Ownership snapshot
Top reported holders of BTCY - BIOTRICITY INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Norman M. Betts
Disclosed value leader
Norman M. Betts
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5
13F
Highest disclosed value: $1,145,574
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Norman M. Betts has the largest disclosed position value at $1.15M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Norman M. Betts's linked filing trail.
Disclosed position value
Top 5
Norman M. Betts
$1.15M
VANGUARD GROUP INC
$151.8K
GEODE CAPITAL MANAGEMENT, LLC
$94.8K
Advisor Resource Council
$90.9K
Strengthening Families & Communit...
$71K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Norman M. Betts |
3/4/5
Director
|
—
denominator unverified
|
$1,145,574
375,598 shares
|
— | 29 Nov 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$151,812
102,576 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$94,847
64,074 shares
|
— | 31 Mar 2024 |
| Advisor Resource Council |
13F
Company
|
—
denominator unverified
|
$90,931
79,070 shares
|
— | 31 Mar 2024 |
| Strengthening Families & Communities, LLC |
13F
Company
|
—
denominator unverified
|
$71,000
48,263 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$33,371
22,548 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
481,039
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q2 2026 Across Filers
Q2 2026 holders
1
Q2 2024 holders
19
Holder diff
18
| Investor | Q2 2026 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q2 2026 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend